Aspire Biopharma's Subsidiary to Feature BUZZ BOMB(TM) at The Health & Fitness Show 2026 [Yahoo! Finance]
Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack [Yahoo! Finance]
Aspire Biopharma's Buzz Bomb(TM) Caffeine Company Achieves Record Social Media Growth and Sales Surge Following World-Record Marathon Sponsorship [Yahoo! Finance]
Aspire Biopharma regains Nasdaq minimum bid price compliance [Seeking Alpha]
Aspire Biopharma (NASDAQ:ASBP) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.